Position in BIIB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$432,120
+$65,460 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#596
of 1,031 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Estabrook Capital Management holds $58,767,979 across 13 Drug Manufacturers - General names. BIIB ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,720 | $22,786,188 | |
| 2 | MRK |
Merck & Co., Inc.
|
96,811 | $12,440,213 | |
| 3 | PFE |
Pfizer Inc
|
324,099 | $7,804,303 | |
| 4 | AMGN |
Amgen Inc
|
18,721 | $6,779,248 | |
| 5 | LLY |
ELI LILLY & Co
|
3,705 | $4,443,888 | |
| 6 | ABBV |
AbbVie Inc.
|
12,861 | $3,236,342 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,515 | $548,254 | |
| 8 | BIIB |
Biogen Inc.
This page
|
2,000 | $432,120 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $432,120 | 2,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $366,660 | 2,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $351,980 | 2,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $280,160 | 2,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $251,180 | 2,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $278,195 | 2,033 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $310,886 | 2,033 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $394,076 | 2,033 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $471,290 | 2,033 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $438,375 | 2,033 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $526,079 | 2,033 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $522,501 | 2,033 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $579,100 | 2,033 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $565,234 | 2,033 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,116,818 | 4,033 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,076,811 | 4,033 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $822,490 | 4,033 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $849,349 | 4,033 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $967,597 | 4,033 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,131,960 | 4,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,385,080 | 4,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,517,750 | 9,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,203,740 | 9,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,553,120 | 9,000 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,407,950 | 9,000 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,163,800 | 10,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||